Phio Pharmaceuticals Corp. (PHIO) Tops Q3 EPS by 260c
Tweet
Share
E-mailGet Alerts PHIO Hot Sheet
Join SI Premium – FREE
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q3 EPS of ($1.54), $2.60 better than the analyst estimate of ($4.14).
For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Motilal Oswal Securities Starts V2 Retail Ltd (VREL:IN) at Buy
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
